Galera Therapeutics, Inc. Financial Ratios — GRTX Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-44.28	-49.12	-71.54	-96.21	-97.72	-168.38	-104.61	1,723.41
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-39.4
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	8.81
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	1	1	- -	- -	1	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	1	- -	- -	- -	1	- -	- -
Total Debt/EBITDA	- -	- -	-0.02	-0.01	- -	- -	-0.03	- -	- -
Net Debt/EBITDA	0.26	0.61	0.36	0.23	0.27	0.08	0.39	0.59	1.06
Total Debt/EBIT	- -	- -	-0.02	-0.01	- -	- -	-0.03	- -	- -
Net Debt/EBIT	0.26	0.61	0.36	0.22	0.27	0.08	0.39	0.59	1.06
EBITDA to Interest Expense	- -	-109.67	-16.64	-14.38	-10.09	-4.42	-4.09	- -	- -
EBITDA-CapEx/Interest Expense	- -	-111.25	-16.84	-14.48	-10.13	-4.42	-4.1	- -	- -
EBIT to Interest Expense	- -	-110.25	-16.72	-14.46	-10.2	-4.43	-4.11	- -	- -
Interest Expense	- -	- -	3	5	7	12	11	- -	- -
Common Equity/Total Assets	-403.25	-119.04	-130.76	-280.08	-379.39	-859.06	-1,673.05	-4,517.26	-4,269.58
Long-Term Debt/Equity (%)	- -	- -	0.77	4.84	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.33	-0.13	-0.01	- -	-0.26	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.43	0.35	0.05	- -	4.27	- -	- -
Total Debt/Equity (%)	- -	- -	1.19	8.73	-0.52	-0.04	-0.95	- -	- -
Total Debt/Capital (%)	- -	- -	-0.52	-0.23	-0.1	-0.01	-0.29	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.67	0.63	0.36	0.1	4.78	- -	- -
Net Debt to Equity	8.11	14.13	-26.37	-259.43	34.24	3.91	13.92	5.77	-97.31
Net Debt/Capital (%)	7.5	12.38	10.26	6.33	5.92	1.12	4.02	1.8	2.05
EBITDA	-24	-24	-50	-70	-73	-51	-47	-14	-6
EBITDA-CapEx	-24	-24	-51	-71	-73	-51	-47	-14	-6
Operating Income (Loss)	-24	-24	-51	-71	-73	-51	-47	-14	-6

Liquidity (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.3	12.65	11.58	5.21	5.51	2.36	3.68	4.98	9.88
Current Ratio	3.53	13.01	12.13	5.58	5.98	2.88	4.36	6	11
Quick Ratio	3.42	12.79	11.58	5.21	5.51	2.36	3.68	5.36	9.88
CFO/Avg Current Liab	- -	-4.13	-5.78	-5.03	-5.05	-3.3	-4.89	-3.67	-5.23
Common Equity/Total Assets	-403.25	-119.04	-130.76	-280.08	-379.39	-859.06	-1,673.05	-4,517.26	-4,269.58
Long-Term Debt/Equity (%)	- -	- -	0.77	4.84	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-0.33	-0.13	-0.01	- -	-0.26	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	0.43	0.35	0.05	- -	4.27	- -	- -
Total Debt/Equity (%)	- -	- -	1.19	8.73	-0.52	-0.04	-0.95	- -	- -
Total Debt/Capital (%)	- -	- -	-0.52	-0.23	-0.1	-0.01	-0.29	- -	- -
Total Debt/Total Assets (%)	- -	- -	0.67	0.63	0.36	0.1	4.78	- -	- -
CFO/Total Liabilities	-24.64	-11.49	-86.78	-76.35	-48.09	-28.34	-28.51	-7.9	-937.83
CFO/CapEx	-73.37	-63.88	-73.71	-130.28	-240.13	-1,737.04	-760.14	- -	- -
Altman's Z-Score	-11	-1.58	1.45	-4.04	-7.07	-16.19	-32.46	-66.88	-61.48

Working Capital (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	327	254	118	40	6	3	- -
- Cash & Cash Equivalents	6	15	18	16	20	4	18	8	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	4	3
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	1	1	- -	- -	1	- -	- -
Enterprise Value	-14	-82	215	182	47	9	-11	-1	-4
Total Capital	-76	-105	-160	-235	-316	-378	-436	-452	-305
Total Debt/Capital (%)	- -	- -	-0.52	-0.23	-0.1	-0.01	-0.29	- -	- -
Total Debt / EV	- -	- -	- -	- -	0.01	- -	-0.12	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	327	254	118	40	6	3	- -
Diluted Enterprise Value	-6	-15	309	239	99	36	-11	-1	-4
EV per Share	- -	- -	8.67	7.33	1.84	0.33	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-24	-24	-50	-70	-73	-51	-47	-14	-6
TTM Operating Income	-24	-24	-51	-71	-73	-51	-47	-14	-6
TTM Cash Flow to Firm	-23	-22	-44	-55	-61	-32	-33	-12	-6
TTM Free Cash Flow to Firm	-23	-22	-43	-54	-60	-32	-33	-12	-6

Multiples (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-7.09	-4.31	-1.75	-0.93	-0.14	-0.21	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-14	-82	215	182	47	9	-11	-1	-4
Low Price	- -	- -	8.16	5.58	1.19	1.12	0.09	0.02	0.02
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.83	-3.54	-2.47	-0.8	-1.21	-0.36	- -
Price/Earnings High	- -	- -	-7.14	-6.53	-4.16	-2.02	-2.71	-0.84	- -
Price/Earnings Low	- -	- -	-3.9	-1.87	-0.38	-0.49	-0.06	-0.06	- -
Price/Book Value	- -	- -	-2.02	-1.08	-0.37	-0.11	-0.01	-0.01	- -
Price/Book Value Average	- -	- -	-1.88	-1.12	-0.63	-0.13	-0.16	-0.01	- -
Price/Book Value High	- -	- -	-2.3	-2.06	-1.06	-0.33	-0.37	-0.03	- -
Price/Book Value Low	- -	- -	-1.25	-0.59	-0.1	-0.08	-0.01	- -	- -
Price/Tangible Book Value	- -	- -	4.91	85.4	-1.94	-0.36	-0.05	-0.02	- -
Price/Tangible Book Value Average	- -	- -	4.55	88.27	-3.25	-0.44	-0.53	-0.05	- -
Price/Tangible Book Value High	- -	- -	5.58	162.79	-5.48	-1.12	-1.19	-0.11	- -
Price/Tangible Book Value Low	- -	- -	3.05	46.58	-0.5	-0.27	-0.03	-0.01	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-7	-4.27	-1.74	-0.93	-0.14	-0.21	- -
Price/Cash Flow Average	- -	- -	-6.48	-4.42	-2.92	-1.14	-1.59	-0.56	- -
Price/Cash Flow High	- -	- -	-7.94	-8.15	-4.93	-2.9	-3.57	-1.3	- -
Price/Cash Flow Low	- -	- -	-4.34	-2.33	-0.45	-0.7	-0.08	-0.09	- -
Price/Free Cash Flow Average	- -	- -	-6.57	-4.45	-2.94	-1.14	-1.59	-0.56	- -
Price/Free Cash Flow High	- -	- -	-8.05	-8.21	-4.95	-2.9	-3.57	-1.3	- -
Price/Free Cash Flow Low	- -	- -	-4.4	-2.35	-0.45	-0.7	-0.08	-0.09	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.26	0.61	-5.65	-3.53	-2.47	-0.89	-1.16	-0.2	0.63
EV/EBITDA High	0.26	0.61	-7	-6.69	-4.35	-2.38	-3.06	-0.84	0.63
EV/EBITDA Low	0.26	0.61	-3.67	-1.76	-0.15	-0.51	0.28	0.2	0.63
EV/EBIT Average	0.26	0.61	-5.62	-3.51	-2.44	-0.89	-1.16	-0.2	0.63
EV/EBIT High	0.26	0.61	-6.97	-6.66	-4.3	-2.38	-3.04	-0.84	0.63
EV/EBIT Low	0.26	0.61	-3.65	-1.75	-0.15	-0.51	0.28	0.2	0.63
Last Price	- -	- -	13.16	10.23	4.59	1.49	0.15	0.05	0.02
High Price	- -	- -	14.94	19.5	12.99	4.65	3.59	0.29	0.06
Enterprise Value Average	-6	-15	285	248	179	45	54	3	-4
Enterprise Value High	-6	-15	353	470	315	122	143	12	-4
Enterprise Value Low	-6	-15	185	123	11	26	-13	-3	-4

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	24	24	25	25	26	29	54	75	75
Diluted Weighted Avg Shares	15	19	25	25	26	27	45	55	- -
Basic Weighted Avg Shares	15	19	25	25	26	27	45	55	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-1.58	-1.25	-2.03	-2.82	-2.81	-1.89	-1.05	-0.26	- -
Operating Income per Share	-1.58	-1.25	-2.04	-2.84	-2.84	-1.89	-1.05	-0.26	- -
Basic EPS, GAAP	-1.55	-1.22	-2.09	-2.98	-3.12	-2.3	-1.33	-0.35	- -
Basic EPS from Cont Ops	-1.55	-1.22	-2.09	-2.98	-3.12	-2.3	-1.33	-0.35	- -
Diluted EPS, GAAP	-1.55	-1.22	-2.09	-2.98	-3.12	-2.3	-1.33	-0.35	- -
Diluted EPS from Cont Ops	-1.55	-1.22	-2.09	-2.98	-3.12	-2.3	-1.33	-0.35	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.54	-1.14	-1.88	-2.39	-2.64	-1.6	-1.01	-0.22	- -
Free Cash Flow per Basic Share	-1.56	-1.16	-1.91	-2.41	-2.65	-1.6	-1.01	-0.22	- -
Cash & Equivalents per Share	0.93	4.21	4.53	2.93	2.76	1.17	0.41	0.15	- -
Book Value per Share	-5	-5.41	-6.5	-9.47	-12.26	-13.97	-9.82	-8.35	- -
Tangible Book Value per Share	-5.21	-5.58	2.68	0.12	-2.37	-4.15	-3.02	-2.71	- -

Galera Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)